Skip to main content
Premium Trial:

Request an Annual Quote

Illumina Announces First Japanese Certified Service Provider

NEW YORK (GenomeWeb News) – Mitsubishi Chemical Safety Institute has become the first Illumina certified genetic analysis service provider in Japan, Illumina announced today.
The Mitsubishi Chemical Safety Institute provides various analyses and services for pharmaceutical and chemical companies as well as for public institutions. It also offers whole-genome and targeted genotyping services using Illumina’s Infinium and GoldenGate assays.
Because of its involvement in toxicogenomic and pharmacogenomic investigations, MCSI “has acquired an abundance of experience in the development of genomic analysis technologies,” said Masaru Sekijima, general manager of the Advanced Medical Science Research Center at MCSI.
Companies participating in Illumina’s certified service provider program are required to undergo a certification process based on data generation and data certification in addition to an on-site facility and process audit.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.